Wnt/β-catenin signaling is a master regulator of the renin-angiotensin system, highlighting its potential as a therapeutic target for hypertension and chronic kidney disease.
No takes yet. Share an insight, caveat, or question.
Wnt/β-catenin inhibition may modulate RAS in CKD; leaves open clinical translation to human hypertension or kidney disease.
Zhou et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: